NIH-funded research R01 grant

BRIDGES-YAS!: Helping young adult cancer survivors move to adult care remotely

Official title: Randomized Controlled Trial of a Remote, Multi-level Intervention to Successfully Transition to Adult Care for Survivors of Childhood and Adolescent Cancers: The BRIDGES-YAS! Study

Funded at Georgetown University · NIH-11441347 · Data updated 2026-11-12

A large study tests a remote, multi-level plan to help young adult survivors of childhood cancer smoothly switch to adult primary care and stay on track with survivorship care.

More Randomized Controlled Trial research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionGeorgetown University
NIH-funded
Lab location1 site (Washington, United States)
Project startSeptember 9, 2026
Project endAugust 31, 2030
Funding year2026
Award (this year)$2,939,368
NIH project number1R01CA303073-01A1
Project IDNIH-11441347 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+ years) who survived childhood cancer and are transitioning to adult primary care.

Less likely to help

Survivors who are already fully integrated into adult PCP care or do not have access to telehealth may see limited benefit.

What this research studies

This project aims to make transitioning from pediatric cancer care to adult care easier for young adult survivors by using telehealth, nurse navigators, and community doctors. It compares two approaches over a year: a remote, multi-level transition program vs the usual pediatric-centered follow-up with basic transition information. Participants will include survivors around 21+ years old who are active in ongoing survivorship care, with education and self-management training provided remotely. The study looks at how well the remote approach works in real-world settings and how to implement it broadly if successful.

Why it matters

Potential benefit: If successful, this approach could improve adherence to lifelong survivorship care and reduce gaps in follow-up for young adult cancer survivors.

How similar studies have gone: Past programs with transitional support show promise, but this remote, multi-level approach is a novel extension.

Where this research is happening

  • Georgetown University
    Washington, United States
    Active

Researchers

  • Principal investigator: Kadan-Lottick, Nina S — Georgetown University
  • Study coordinator: Kadan-Lottick, Nina S

Related research

Other NIH-funded projects on the same topics.

  • Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure

    A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.

    NIH research Pennsylvania State Univ Hershey Med Ctr · Hershey, United States · NIH-11635771

  • Shorter antifungal treatment for kids with candidemia

    A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606539

  • Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia

    This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606535

  • Shorter antifungal treatment for kids with candidemia

    A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606531

  • Shorter antifungal treatment for kids with candidemia

    This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606505

  • Shorter antifungal course for kids with candidemia

    A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606502

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.